Diagnostic Approach for Gastroesophageal Reflux Disease (GERD)

Initial Symptom Assessment

The American Gastroenterological Association recommends that the diagnosis of GERD should begin with evaluation of typical symptoms, followed by an empiric PPI trial in patients with these symptoms, while those with atypical or extraesophageal symptoms should undergo early objective testing rather than empiric therapy 1, 2
Typical GERD symptoms include heartburn and regurgitation, which have the highest specificity for diagnosing GERD 3
Atypical symptoms may include dysphagia, chest pain, chronic cough, laryngitis, asthma, dental erosions, and other extraesophageal manifestations 4

For patients with typical GERD symptoms, the initial approach is an empiric 4-8 week trial of once-daily PPI therapy, with adjustment to twice daily or a more effective agent if inadequate response, and tapering to the lowest effective dose if adequate response 2
If symptoms persist despite PPI therapy, proceed to endoscopy to evaluate for esophagitis, Barrett's esophagus, or alternative diagnoses, and consider esophageal manometry followed by ambulatory reflux monitoring if endoscopy is normal 1, 7

Endoscopy is recommended for patients with alarm symptoms or who fail to respond to empiric PPI therapy, and should include assessment for erosive esophagitis, evaluation of diaphragmatic hiatus and hiatal hernia, and inspection for Barrett's esophagus with biopsy when present 1, 2, 5
Ambulatory reflux monitoring options include catheter-based pH monitoring, wireless pH capsule, and combined impedance-pH monitoring, and should be performed off PPI therapy unless testing for refractory symptoms in patients with previously confirmed GERD 1, 2, 7
Esophageal manometry is used to localize the lower esophageal sphincter, evaluate peristaltic function, and diagnose alternative motility disorders that may mimic GERD 1

Extraesophageal reflux disease diagnosis requires a global clinical impression from symptoms, treatment response, endoscopy, and reflux testing, and no single diagnostic tool can conclusively identify GERD as the cause of extraesophageal symptoms 8, 9
Refractory GERD management involves pH-impedance monitoring on PPI therapy to evaluate ongoing acid or non-acid reflux, and helps determine if persistent symptoms are related to reflux or other causes 2, 7

Relying solely on symptom response to PPI as confirmation of GERD diagnosis, as improvement may occur through mechanisms other than acid suppression 8
Continuing long-term PPI therapy without objective confirmation of GERD 2
Assuming all extraesophageal symptoms are due to GERD without proper testing 4, 9
Failing to consider alternative diagnoses that may mimic GERD 1